R.G. Masterton

3.0k total citations
61 papers, 2.0k citations indexed

About

R.G. Masterton is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Infectious Diseases. According to data from OpenAlex, R.G. Masterton has authored 61 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 17 papers in Applied Microbiology and Biotechnology and 16 papers in Infectious Diseases. Recurrent topics in R.G. Masterton's work include Antibiotic Use and Resistance (17 papers), Bacterial Identification and Susceptibility Testing (16 papers) and Antibiotic Resistance in Bacteria (15 papers). R.G. Masterton is often cited by papers focused on Antibiotic Use and Resistance (17 papers), Bacterial Identification and Susceptibility Testing (16 papers) and Antibiotic Resistance in Bacteria (15 papers). R.G. Masterton collaborates with scholars based in United Kingdom, United States and Spain. R.G. Masterton's co-authors include H. Lode, Giuseppe Cornaglia, Jordi Rello, G.L. French, Ronald N. Jones, Philip J. Turner, Mark L. Metersky, Timothy Babinchak, Thomas M. File and Dilip Nathwani and has published in prestigious journals such as Clinical Infectious Diseases, Intensive Care Medicine and Journal of Antimicrobial Chemotherapy.

In The Last Decade

R.G. Masterton

60 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.G. Masterton United Kingdom 26 829 544 517 435 404 61 2.0k
Mercedes Palomar Spain 26 1.1k 1.3× 781 1.4× 880 1.7× 264 0.6× 437 1.1× 96 2.4k
Nicolas Troillet Switzerland 21 586 0.7× 611 1.1× 336 0.6× 710 1.6× 531 1.3× 82 2.4k
Julia Moody United States 23 577 0.7× 1.1k 1.9× 290 0.6× 306 0.7× 329 0.8× 55 2.3k
A.P.R. Wilson United Kingdom 28 614 0.7× 1.2k 2.2× 288 0.6× 428 1.0× 418 1.0× 78 2.5k
D. Sohr Germany 30 795 1.0× 851 1.6× 739 1.4× 296 0.7× 329 0.8× 74 2.8k
Koenraad Vandewoude Belgium 23 1.4k 1.7× 1.0k 1.9× 664 1.3× 306 0.7× 419 1.0× 34 2.8k
Amos M. Yinnon Israel 31 1.2k 1.5× 827 1.5× 306 0.6× 604 1.4× 346 0.9× 125 3.0k
Shailendra N. Banerjee United States 13 530 0.6× 408 0.8× 428 0.8× 364 0.8× 197 0.5× 17 1.9k
Dimitrios K. Matthaiou Greece 26 1.0k 1.2× 522 1.0× 364 0.7× 1.0k 2.4× 438 1.1× 49 2.6k
Abraham Borer Israel 25 806 1.0× 523 1.0× 199 0.4× 945 2.2× 369 0.9× 93 2.1k

Countries citing papers authored by R.G. Masterton

Since Specialization
Citations

This map shows the geographic impact of R.G. Masterton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.G. Masterton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.G. Masterton more than expected).

Fields of papers citing papers by R.G. Masterton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.G. Masterton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.G. Masterton. The network helps show where R.G. Masterton may publish in the future.

Co-authorship network of co-authors of R.G. Masterton

This figure shows the co-authorship network connecting the top 25 collaborators of R.G. Masterton. A scholar is included among the top collaborators of R.G. Masterton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.G. Masterton. R.G. Masterton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mackay, William G., et al.. (2014). A review of infection control in community healthcare: new challenges but old foes. European Journal of Clinical Microbiology & Infectious Diseases. 33(12). 2121–2130. 2 indexed citations
2.
Masterton, R.G., Giuseppe Cornaglia, Patrice Courvalin, et al.. (2014). The clinical positioning of telavancin in Europe. International Journal of Antimicrobial Agents. 45(3). 213–220. 18 indexed citations
3.
Christie, P, et al.. (2012). Nasal Swab Screening for Methicillin-Resistant Staphylococcus aureus—How Well Does It Perform? A Cross-Sectional Study. Infection Control and Hospital Epidemiology. 33(8). 803–808. 48 indexed citations
4.
Reilly, J., Sally Stewart, P Christie, et al.. (2011). Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study. Journal of Hospital Infection. 80(1). 31–35. 33 indexed citations
5.
Rello, Jordi, et al.. (2010). A European care bundle for prevention of ventilator-associated pneumonia. Intensive Care Medicine. 36(5). 773–780. 162 indexed citations
6.
Nathwani, Dilip, Marina S. Morgan, R.G. Masterton, et al.. (2008). Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. Journal of Antimicrobial Chemotherapy. 61(5). 976–994. 168 indexed citations
7.
Masterton, R.G., A. Galloway, G.L. French, et al.. (2008). Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy. Journal of Antimicrobial Chemotherapy. 62(1). 5–34. 219 indexed citations
8.
Masterton, R.G., D. E. Craven, Jordi Rello, et al.. (2007). Hospital-acquired pneumonia guidelines in Europe: a review of their status and future development. Journal of Antimicrobial Chemotherapy. 60(2). 206–213. 32 indexed citations
9.
10.
Williams, Craig & R.G. Masterton. (2007). Pneumococcal immunisation in the 21st century. Journal of Infection. 56(1). 13–19. 7 indexed citations
11.
Masterton, R.G.. (2007). The place of guidelines in hospital-acquired pneumonia. Journal of Hospital Infection. 66(2). 116–122. 8 indexed citations
12.
Jones, Ronald N., Carlos Maurício Cardeal Mendes, Philip J. Turner, & R.G. Masterton. (2005). An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997–2004. Diagnostic Microbiology and Infectious Disease. 53(4). 247–256. 36 indexed citations
13.
Ünal, Serhat, R.G. Masterton, & Herman Goossens. (2004). Bacteraemia in Europe—antimicrobial susceptibility data from the MYSTIC surveillance programme. International Journal of Antimicrobial Agents. 23(2). 155–163. 27 indexed citations
14.
Masterton, R.G., Joseph L. Kuti, Philip J. Turner, & David P. Nicolau. (2004). The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe. Journal of Antimicrobial Chemotherapy. 55(1). 71–77. 54 indexed citations
15.
Masterton, R.G., L. Teare, & Julie Richards. (2002). Hospital Infection Society/Association of Medical Microbiologists ‘Towards a Consensus II’ Workshop I Hospital-acquired infection and risk management. Journal of Hospital Infection. 51(1). 17–20. 2 indexed citations
16.
Masterton, R.G., et al.. (2001). Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis. International Journal of Antimicrobial Agents. 18(6). 503–512. 54 indexed citations
17.
Masterton, R.G., et al.. (1995). High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women. Journal of Antimicrobial Chemotherapy. 35(1). 129–137. 55 indexed citations
18.
More, I. A. R. & R.G. Masterton. (1976). The role of oestrogen in the control of ciliated cells of the human endometrium. Reproduction. 47(1). 19–24. 13 indexed citations
19.
Masterton, R.G., et al.. (1975). THE CYCLICAL VARIATION IN THE PERCENTAGE OF CILIATED CELLS IN THE NORMAL HUMAN ENDOMETRIUM. Reproduction. 42(3). 537–540. 30 indexed citations
20.
More, I. A. R. & R.G. Masterton. (1975). THE FINE STRUCTURE OF THE HUMAN ENDOMETRIAL CILIATED CELL. Reproduction. 45(2). 343–348. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mercedes Palomar Breakdown of academic impact, for papers by Nicolas Troillet Breakdown of academic impact, for papers by Julia Moody Breakdown of academic impact, for papers by A.P.R. Wilson Breakdown of academic impact, for papers by D. Sohr Breakdown of academic impact, for papers by Koenraad Vandewoude Breakdown of academic impact, for papers by Amos M. Yinnon Breakdown of academic impact, for papers by Shailendra N. Banerjee Breakdown of academic impact, for papers by Dimitrios K. Matthaiou Breakdown of academic impact, for papers by Abraham Borer
Rankless by CCL
2026